SMTL ID : 7kl9.1

Structure of the SARS-CoV-2 S 6P trimer in complex with the ACE2 protein decoy, CTC-445.2 (State 4)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 3 residues within 4Å: Chain C: E.132, N.164, N.165 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 2 residues within 4Å: Chain C: N.331, I.332 No protein-ligand interaction detected (PLIP)

27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.3: 5 residues within 4Å: Chain A: N.280, E.281, N.282, T.284 Chain C: K.558 Ligand excluded by PLIP NAG.4: 2 residues within 4Å: Chain A: N.603, T.604 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: H.655, V.656, N.657 Ligand excluded by PLIP NAG.6: 1 residues within 4Å: Chain A: N.1074 Ligand excluded by PLIP NAG.7: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.8: 1 residues within 4Å: Chain A: N.616 Ligand excluded by PLIP NAG.9: 1 residues within 4Å: Chain A: N.331 Ligand excluded by PLIP NAG.10: 3 residues within 4Å: Chain A: N.709, G.1131 Chain B: D.796 Ligand excluded by PLIP NAG.11: 2 residues within 4Å: Chain B: E.281, N.282 Ligand excluded by PLIP NAG.12: 1 residues within 4Å: Chain B: N.603 Ligand excluded by PLIP NAG.13: 1 residues within 4Å: Chain B: N.657 Ligand excluded by PLIP NAG.14: 4 residues within 4Å: Chain B: A.706, E.1072, K.1073, N.1074 Ligand excluded by PLIP NAG.15: 2 residues within 4Å: Chain B: Y.28, N.61 Ligand excluded by PLIP NAG.16: 1 residues within 4Å: Chain B: N.616 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain B: N.122, A.123, T.124, N.125 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain A: R.357 Chain B: E.132, N.165 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain B: G.232, I.233, N.234 Ligand excluded by PLIP NAG.20: 3 residues within 4Å: Chain B: N.709, G.1131 Chain C: D.796 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain B: N.331 Ligand excluded by PLIP NAG.22: 2 residues within 4Å: Chain C: E.281, N.282 Ligand excluded by PLIP NAG.23: 1 residues within 4Å: Chain C: N.603 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain C: H.655, N.657 Ligand excluded by PLIP NAG.25: 3 residues within 4Å: Chain C: E.1072, K.1073, N.1074 Ligand excluded by PLIP NAG.26: 2 residues within 4Å: Chain C: N.30, N.61 Ligand excluded by PLIP NAG.27: 2 residues within 4Å: Chain C: N.616, Q.644 Ligand excluded by PLIP NAG.28: 5 residues within 4Å: Chain C: N.122, A.123, T.124, N.125, V.127 Ligand excluded by PLIP NAG.29: 3 residues within 4Å: Chain A: D.796 Chain C: N.709, G.1131 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Linsky, T.W. et al., De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2. Science (2020)

Release Date

2020-11-11

Peptides

Spike glycoprotein: ABC
CTC-445.2 inhibitor: DEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
E

E
D

F
F

Spike glycoprotein

CTC-445.2 inhibitor